Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Verification Study of JNS020QD in Patients With Post-herpetic Neuralgia, Complex Regional Pain Syndrome (CRPS) or Postoperative Pain Syndrome

Next Previous
Search
Trial Profile

A Verification Study of JNS020QD in Patients With Post-herpetic Neuralgia, Complex Regional Pain Syndrome (CRPS) or Postoperative Pain Syndrome

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 14 Jan 2020

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Fentanyl (Primary)
  • Indications Complex regional pain syndromes; Postherpetic neuralgia; Postoperative pain
  • Focus Registrational; Therapeutic Use
  • Sponsors Janssen Pharmaceutical KK

Most Recent Events

  • 24 Jul 2013 Actual initiation date changed from Sep 2008 to Dec 2008 as reported by ClinicalTrials.gov.
  • 15 Jul 2010 Actual end date changed from 1 Feb 2010 to 1 Mar 2010 as reported by ClinicalTrials.gov.
  • 06 Mar 2010 Actual end date (February 2010) added as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top